Fikret Aysal

661 total citations
30 papers, 357 citations indexed

About

Fikret Aysal is a scholar working on Neurology, Infectious Diseases and Surgery. According to data from OpenAlex, Fikret Aysal has authored 30 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 8 papers in Infectious Diseases and 7 papers in Surgery. Recurrent topics in Fikret Aysal's work include Myasthenia Gravis and Thymoma (13 papers), Peripheral Neuropathies and Disorders (12 papers) and Antifungal resistance and susceptibility (8 papers). Fikret Aysal is often cited by papers focused on Myasthenia Gravis and Thymoma (13 papers), Peripheral Neuropathies and Disorders (12 papers) and Antifungal resistance and susceptibility (8 papers). Fikret Aysal collaborates with scholars based in Türkiye, United States and Germany. Fikret Aysal's co-authors include Güher Saruhan‐Direskeneli, Piraye Oflazer, Feza Deymeer, Vuslat Yılmaz, Hacer Durmuş, Mahdi Behzad, Alexander Marx, Yeşim Parman, Sibel P. Yentür and Öner Doğan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Fikret Aysal

26 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fikret Aysal Türkiye 10 255 86 52 43 42 30 357
Zhe Ruan China 11 149 0.6× 58 0.7× 52 1.0× 31 0.7× 10 0.2× 40 338
Vittorio Mantero Italy 11 183 0.7× 58 0.7× 14 0.3× 62 1.4× 18 0.4× 32 288
Michael Pulley United States 6 229 0.9× 73 0.8× 9 0.2× 19 0.4× 28 0.7× 17 319
R. Taiuti Italy 7 243 1.0× 19 0.2× 43 0.8× 143 3.3× 50 1.2× 18 355
Seyed Mohammad Baghbanian Iran 9 88 0.3× 40 0.5× 32 0.6× 132 3.1× 11 0.3× 43 236
B Garabedian France 10 300 1.2× 41 0.5× 48 0.9× 13 0.3× 14 0.3× 13 400
Lars Hendrik Müschen Germany 9 132 0.5× 14 0.2× 54 1.0× 79 1.8× 14 0.3× 13 307
Elisa Vegezzi Italy 8 112 0.4× 38 0.4× 10 0.2× 29 0.7× 68 1.6× 26 209
Roger E. Farber United States 10 112 0.4× 19 0.2× 20 0.4× 90 2.1× 29 0.7× 12 289
Nuria García‐Barragán Spain 10 264 1.0× 28 0.3× 24 0.5× 197 4.6× 22 0.5× 20 392

Countries citing papers authored by Fikret Aysal

Since Specialization
Citations

This map shows the geographic impact of Fikret Aysal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fikret Aysal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fikret Aysal more than expected).

Fields of papers citing papers by Fikret Aysal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fikret Aysal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fikret Aysal. The network helps show where Fikret Aysal may publish in the future.

Co-authorship network of co-authors of Fikret Aysal

This figure shows the co-authorship network connecting the top 25 collaborators of Fikret Aysal. A scholar is included among the top collaborators of Fikret Aysal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fikret Aysal. Fikret Aysal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tüzün, Erdem, Arman Çakar, Aysun Soysal, et al.. (2023). Disease activity in chronic inflammatory demyelinating polyneuropathy: association between circulating B-cell subsets, cytokine levels, and clinical outcomes. Clinical & Experimental Immunology. 215(1). 65–78. 1 indexed citations
2.
Durmuş, Hacer, Fikret Aysal, Behzat Özkan, et al.. (2020). CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS. Frontiers in Immunology. 11. 809–809. 40 indexed citations
3.
Yılmaz, Vuslat, Erdem Tüzün, Hacer Durmuş, et al.. (2020). The treatment effect on peripheral B cell markers in antibody positive myasthenia gravis patients. Journal of Neuroimmunology. 349. 577402–577402. 1 indexed citations
4.
Polat, Burcu, et al.. (2017). Blink Reflex in Episodic and Chronic Migraine. Nöro Psikiyatri Arşivi. 55(2). 146–151. 2 indexed citations
5.
Saruhan‐Direskeneli, Güher, Travis K. Hughes, Vuslat Yılmaz, et al.. (2016). Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis. Clinical Immunology. 166-167. 81–88. 33 indexed citations
6.
Matur, Zeliha, et al.. (2016). Clinical, Electrophysiological, and Serological Evaluation of Patients with Cramp-Fasciculation Syndrome. Nöro Psikiyatri Arşivi. 54(2). 183–186. 9 indexed citations
7.
8.
Yılmaz, Vuslat, Piraye Oflazer, Fikret Aysal, et al.. (2015). Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK. PLoS ONE. 10(4). e0123546–e0123546. 42 indexed citations
9.
Örmeci, Tuğrul, Mahir Mahiroğulları, & Fikret Aysal. (2015). Tarsal tunnel syndrome masked by painful diabetic polyneuropathy. International Journal of Surgery Case Reports. 15(C). 103–106. 2 indexed citations
10.
Köksal, Ayhan, et al.. (2014). Evaluation of Cognitive Characteristics of Patients Developing Manifestations of Parkinsonism Secondary to Long-Term Ephedrone Use. European Neurology. 71(3-4). 208–212. 7 indexed citations
11.
Yılmaz, Vuslat, Piraye Oflazer, Fikret Aysal, et al.. (2014). The Association of PTPN22 R620W Polymorphism Is Stronger with Late-Onset AChR-Myasthenia Gravis in Turkey. PLoS ONE. 9(8). e104760–e104760. 7 indexed citations
12.
Yılmaz, Vuslat, Piraye Oflazer, Fikret Aysal, et al.. (2014). B cells produce less IL-10, IL-6 and TNF-αin myasthenia gravis. Autoimmunity. 48(4). 201–207. 27 indexed citations
13.
Aysal, Fikret, et al.. (2013). Miyastenia Graviste Anksiyete ve Depresif Belirtilerin, Hastalık Şiddeti ve Tedavi Biçimiyle İlişkisi: Kesitsel Bir Çalışma. Nöro Psikiyatri Arşivi. 50(4). 295–300. 22 indexed citations
14.
Behzad, Mahdi, Vuslat Yılmaz, Fikret Aysal, et al.. (2013). Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey. Human Immunology. 74(12). 1633–1635. 39 indexed citations
15.
Güveli, Betül Tekin, et al.. (2012). İzole Aksiller Sinir Tutulumu: Olgu Sunumu / Isolated Axillary Nerve Involvement: Case Report. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 1 indexed citations
16.
Aysal, Fikret, et al.. (2012). Paraneoplastic extralimbic encephalitis associated with thymoma and myastenia gravis: Three years follow up. Clinical Neurology and Neurosurgery. 115(5). 628–631. 8 indexed citations
17.
Dayan, Colin, et al.. (2010). İnmelerde tekrarlayıcılığı etkileyen risk faktörleri. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 38–43. 1 indexed citations
18.
Dayan, Colin, et al.. (2010). Risk factors that affect recurrence in strokes. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 38–43. 1 indexed citations
19.
Soysal, Aysun, et al.. (2010). Clinico-electrophysiological findings and prognosis of Guillain-Barré syndrome - 10 years’ experience. Acta Neurologica Scandinavica. 123(3). 181–186. 25 indexed citations
20.
Özkara, Çiğdem, Lütfü Hanoğlu, Naz Yeni, et al.. (2004). Memory in Patients with Drug‐responsive Mesial Temporal Lobe Epilepsy and Hippocampal Sclerosis. Epilepsia. 45(11). 1392–1396. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhe Ruan Breakdown of academic impact, for papers by Vittorio Mantero Breakdown of academic impact, for papers by Michael Pulley Breakdown of academic impact, for papers by R. Taiuti Breakdown of academic impact, for papers by Seyed Mohammad Baghbanian Breakdown of academic impact, for papers by B Garabedian Breakdown of academic impact, for papers by Lars Hendrik Müschen Breakdown of academic impact, for papers by Elisa Vegezzi Breakdown of academic impact, for papers by Roger E. Farber Breakdown of academic impact, for papers by Nuria García‐Barragán
Rankless by CCL
2026